Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 1:12 AM
Ignite Modification Date: 2025-12-25 @ 1:12 AM
NCT ID: NCT07270393
Eligibility Criteria: INCLUSION CRITERIA: * Female. * Age 18-45. * Premenopausal status. * Radiological diagnosis (by transvaginal ultrasound and/or MRI) and/or surgical diagnosis of endometriosis. * Follow-up in the Gynecology Department of OSI Donostia (at least 1 visit in the last year). * Clinical score of at least 3/10 on the Numerical Scale in at least one symptom related to endometriosis). * Possibility of understanding Spanish. * Possibility of understanding the indicated dietary recommendations. * Acceptance of inclusion in clinical study, by signing informed consent. EXCLUSION CRITERIA: * Diagnosis of Eating Disorder. * Diagnosis of malabsorptive syndromes: Chron's disease, Ulcerative colitis, short bowel syndrome, gastric by-pass, irritable bowel. * Other concomitant diseases that produce CPD. * Autoimmune diseases.- * Metabolic diseases requiring follow-up of specific diets. * Diagnosed gluten intolerance. * Vegan diet. * Follow-up by a nutritionist. * Diagnosis of severe mental illness requiring treatment. * Pregnancy or current breastfeeding. * Active cancer process. * Personal history of gynecologic or digestive oncologic process. * Change of treatment or surgery during follow-up. * Surgery related to endometriosis or change of treatment in the 6 weeks prior to enrollment in the study. * Drug abuse. Opioid analgesia \< 3 months.
Healthy Volunteers: False
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 45 Years
Study: NCT07270393
Study Brief:
Protocol Section: NCT07270393